Bank of New York Mellon Corp header image

Bank of New York Mellon Corp

BK

Equity

ISIN null / Valor 2824731

New York Stock Exchange, Inc (2026-03-23)
USD 116.36+1.24%

Bank of New York Mellon Corp
UMushroom community rating:

star star star star star
4.00 1 votes No rating yet
NegativeNeutralPositive

About company

The Bank of New York Mellon Corporation, commonly known as BNY Mellon, is a prominent global financial services company headquartered in New York City. It specializes in investment management and investment services, offering a comprehensive range of financial products to institutions, corporations, and individual investors worldwide. BNY Mellon provides asset servicing, wealth management, and treasury services, among other offerings, leveraging its extensive expertise and technology to support clients in managing and servicing their financial assets. As a custodian bank, it plays a critical role in safeguarding and managing the assets of its clients, ensuring efficient and secure transactions. With a history dating back to 1784, BNY Mellon is one of the oldest banking institutions in the United States, known for its stability and innovation in the financial sector.

Summarized from source with an LLMView SourceSector: Finance

Latest Results (10.03.2026):

Bank of New York Mellon Corp — Fourth quarter 2025: BNY reported 4Q25 diluted EPS of $2.02 ($2.08 adjusted), total revenue of $5.18 billion (up 7% vs. 4Q24) and net income applicable to common shareholders of $1.427 billion. The company highlighted record full‑year 2025 results (net income $5.3 billion; revenue $20.1 billion), strong returns (ROTCE 26.6% in 4Q25; FY25 ROTCE 26.1%), continued revenue growth, disciplined expense control and substantial capital returns.

Revenue and fee trends

Total revenue was $5.179 billion in 4Q25, up 7% year‑over‑year. Fee revenue totaled $3.698 billion (up 5% YoY) driven by higher market values, net new business and stronger client activity; net interest income rose 13% YoY to $1.346 billion on reinvestment at higher yields and balance‑sheet growth.

Earnings and profitability

Diluted EPS was $2.02 in 4Q25 (adjusted EPS $2.08). Pre‑tax operating margin was 36% and ROTCE was 26.6% (adjusted ROTCE 27.4%), reflecting eight consecutive quarters of positive operating leverage and year‑over‑year EPS growth (31% reported; 21% excluding notable items).

Expenses and notable items

Noninterest expense was $3.360 billion in 4Q25 (flat YoY; +4% excluding notable items). The quarter included $51 million of notable noninterest items (primarily severance) partially offset by an FDIC special assessment adjustment; adjusted operating leverage and adjusted margins were modestly stronger.

Client assets and business volumes

AUC/A closed at $59.3 trillion (up 14% YoY) and AUM was $2.2 trillion (up 7% YoY), with growth driven by market appreciation, client inflows and a weaker U.S. dollar. Average deposits rose to $310 billion (+8% YoY).

Capital return and ratios

BNY returned capital in 4Q25 (common dividends $377 million; $1.0 billion share repurchases in the quarter). Full‑year 2025 capital returned totaled $5.0 billion. CET1 ratio was 11.9% and Tier 1 leverage ratio was 6.0% (preliminary).

Segment performance highlights

Securities Services revenue was $2.497 billion (+7% YoY) with Asset Servicing and Issuer Services gains; Market & Wealth Services revenue was $1.805 billion (+8% YoY) led by higher net interest income; Investment & Wealth Management revenue was $854 million (down 2% YoY) with AUM up 7%.

Management commentary and outlook

Management described 2025 as a successful, record year, emphasized ongoing multi‑year transformation, reported raised medium‑term targets and signaled entering 2026 with positive momentum to pursue greater scale and growth opportunities.

Summarized from source with an LLMView Source

Key figures

39.3%1Y
169%3Y
162%5Y

Performance

24.4%1Y
22.8%3Y
24.9%5Y

Volatility

Market cap

79929 M

Market cap (USD)

Daily traded volume (Shares)

3,818,657

Daily traded volume (Shares)

1 day high/low

77.3 / 76.26

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

4.00

1 votes
Performance:
starstarstarstarstar
4.00
Innovation:
starstarstarstarstar
4.00
Society:
starstarstarstarstar
4.00
Nature:
starstarstarstarstar
4.00
Josh Lai
United Kingdom, 23 Oct 2025
star star star star star
NA

EQUITIES OF THE SAME SECTOR

Kennedy-Wilson Holdings Inc
Kennedy-Wilson Holdings Inc Kennedy-Wilson Holdings Inc Valor: 10751367
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.37%USD 10.89
Belite Bio Incorporation
Belite Bio Incorporation Belite Bio Incorporation Valor: 118450378
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.23%USD 151.14
Four Corners Property Trust Inc
Four Corners Property Trust Inc Four Corners Property Trust Inc Valor: 30202101
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.49%USD 24.14
Safehold Inc
Safehold Inc Safehold Inc Valor: 125590632
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.83%USD 14.19
Arcturus Therapeutics Holdings Inc
Arcturus Therapeutics Holdings Inc Arcturus Therapeutics Holdings Inc Valor: 48461643
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.62%USD 6.87
UP Fintech Holding Ltd
UP Fintech Holding Ltd UP Fintech Holding Ltd Valor: 46662401
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.96%USD 6.83
Scholar Rock Holding Corporation
Scholar Rock Holding Corporation Scholar Rock Holding Corporation Valor: 41623961
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.20%USD 43.66
CareTrust REIT Inc
CareTrust REIT Inc CareTrust REIT Inc Valor: 22849101
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.74%USD 37.45
Structure Therapeutics Incorporation
Structure Therapeutics Incorporation Structure Therapeutics Incorporation Valor: 124807608
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.97%USD 49.06
American Healthcare REIT Inc
American Healthcare REIT Inc American Healthcare REIT Inc Valor: 121882465
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.08%USD 48.07